New treatment prevents transplant rejection

October 16, 2018, University of Queensland
Credit: CC0 Public Domain

A new treatment strategy could increase the success rate of stem cell transplants, according to University of Queensland researchers.

The approach removes the need for donor matching and the use of immunosuppressant drugs to prevent rejection, and could make stem cell treatment accessible to more patients.

UQ Diamantina Institute researcher Dr. Jatin Patel said researchers found immunosuppressant drugs had a negative impact on the transplanted .

"Patients receiving a donation of stem cells from an unrelated individual normally need to take medication to suppress their immune system to prevent rejection," he said.

"When we injected stem cells to repair blood vessels, we noticed those cells were damaged by the immunosuppressant drugs.

"The stem cells did not work properly and the damaged blood vessels were not repaired.

"We found that without immunosuppression therapy, the delivered stem cells actually functioned better and may have a better likelihood of superior clinical outcomes for the patient."

UQDI dermatologist Associate Professor Kiarash Khosrotehrani said the treatment could be used for patients with chronic wounds caused by diseases such as peripheral vascular disease and limb ischemia.

"Chronically ill patients with extensive lower limb wounds due to poor blood flow are generally unable to undergo invasive surgical procedures and end up with amputation," Dr. Khosrotehrani said.

"Our approach would reduce the burden of these by presenting an option for without the worry of patients getting additional infections while taking immunosuppressive drugs."

Dr. Patel said the new treatment strategy harnessed the cells' existing features.

"The strategy worked by combining two types of stem cells, one of which had 'in-built' immunosuppressant properties," he said.

"When injected together, the stem cells survived and functioned without the need for .

"Our patented technology to isolate these two stem cell types gives us confidence that such therapy can be trialled in patients in the future."

The study is published in Stem Cells Translational Medicine

Explore further: Elusive stem cells could help repair damaged blood vessels

More information: Immunosuppression Agent Cyclosporine Reduces Self‐Renewal and Vessel Regeneration Potentiation of Human Endothelial of Colony Forming Cells. Stem Cells Translational Medicine. doi.org/10.1002/sctm.18-0103

Related Stories

Elusive stem cells could help repair damaged blood vessels

September 26, 2018
A unique source of stem cells in blood helps to build blood vessels in the growing embryo according to new research published in Nature and part-funded by the British Heart Foundation.

Regenerative stem cell active in human blood vessels could help patients with diabetes and cardiovascular disease

December 20, 2016
The discovery of a regenerative stem cell active in human blood vessels could help patients with diabetes and cardiovascular disease.

Some blood stem cells are better than others

May 30, 2018
In your body, blood stem cells produce approximately 10 billion new white blood cells, which are also known as immune cells, each and every day. Even more remarkably, if some of these blood stem cells fail to do their part, ...

Supercharging stem cells to create new therapies

July 3, 2015
Researchers at the University of Adelaide have discovered a new method for culturing stem cells which sees the highly therapeutic cells grow faster and stronger.

'Educating' patients' immune cells may help combat diabetes

July 7, 2017
New research reveals that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy cultures the patient's immune cells with cord blood stem cells and returns ...

No survival advantage with peripheral blood stem cells versus bone marrow

October 19, 2012
(Medical Xpress)—Claudio Anasetti, M.D., chair of the Department of Blood & Marrow Transplant at Moffitt Cancer Center, and colleagues from 47 research sites in the Blood and Marrow Transplant Clinical Trials Network conducted ...

Recommended for you

Scientists uncover new gatekeeper function of anti-aging molecule

November 12, 2018
The protein klotho has been shown to promote longevity and counteract aging-related impairments. Having more klotho seems to allow for longer and healthier lives, whereas a depletion of this molecule accelerates aging and ...

Can scientists change mucus to make it easier to clear, limiting harm to lungs?

November 12, 2018
For healthy people, mucus is our friend. It traps potential pathogens so our airways can dispatch nasty bugs before they cause harm to our lungs. But for people with conditions such as cystic fibrosis (CF) and chronic obstructive ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Researchers explain how your muscles form

November 12, 2018
All vertebrates need muscles to function; they are the most abundant tissue in the human body and are integral to movement.

Defective DNA damage repair leads to chaos in the genome

November 12, 2018
Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found a cause for frequent catastrophic events in the genetic material of cancer cells that have only been known for a few ...

Salmonella found to be resistant to different classes of antibiotics

November 12, 2018
Brazil's Ministry of Health received reports of 11,524 outbreaks of foodborne diseases between 2000 and 2015, with 219,909 individuals falling sick and 167 dying from such diseases. Bacteria caused most outbreaks of such ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.